Reports Q2 revenue $469.1M, consensus $460.7M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EVH:
- Evolent Announces Second Quarter 2023 Results
- Evolent Health announces corporate rebranding as Evolent
- Evolent Health price target lowered to $47 from $50 at Guggenheim
- Evolent selloff on MCOs’ utilization comments ‘way overdone,’ says RBC Capital
- UnitedHealth comments readthrough to Evolent Health overblown, says Canaccord